HCMT
CSTL icon

Highland Capital Management (Texas)’s Castle Biosciences CSTL Stock Holding History

Highland Capital Management (Texas)’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-916,270
Closed -$62.7M – 4
2021
Q1 		$62.7M Hold
916,270
– – 48.51% 1
2020
Q4 		$10M Buy
+916,270
New +$49.7M 10.46% 4

Other funds holding CSTL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

Highland Capital Management (Texas)'s CSTL Position: Q2 2021 in Review

Highland Capital Management (Texas) sold out of Castle Biosciences (CSTL) in Q2 2021, closing a stake of 916,270 shares — an estimated $62.7M sold.

Highland Capital Management (Texas) first reported a position in CSTL in Q4 2020 and held it in 2 quarters. The position peaked at $62.7M in Q1 2021. 181 funds tracked by Wall St. Rank hold CSTL as of Q2 2021.

  • Highland Capital Management (Texas) reported no remaining Castle Biosciences position as of Q2 2021 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 916,270 Castle Biosciences shares in Q2 2021, an estimated $62.7M.
  • Highland Capital Management (Texas) first reported a position in Castle Biosciences in Q4 2020 and held it in 2 quarters.
  • Highland Capital Management (Texas)'s Castle Biosciences position peaked at $62.7M in Q1 2021.
  • 181 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2021.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2021, filed 16 Aug 2021.